On Same Day Mallinckrodt Settles For $15.4M, United States Sues Over Drug Co-Pays

(June 6, 2019, 3:42 PM EDT) -- On the same day Mallinckrodt plc said it reached a $15.4 million agreement-in-principal to settle a U.S. Justice Department investigation into improper sales and marketing by subsidiary Questcor Pharmaceuticals Inc., the Justice Department on June 5 filed a federal complaint alleging that Mallinckrodt contributed to a drug co-pay program at the same time it increased a drug’s price from double to quintuple digits (United States of America, ex rel. Charles Strunck, et al., No. 12-175, E.D. Pa.)....

Attached Documents

Related Sections